Group
ViewWho we are
ViewGovernance
ViewWhat we do
ViewOur strategy
ViewThree trends, source of growth
ViewInnovation
ViewResearch & Development
ViewNew markets & Technologies
ViewSustainable development
ViewQuick Access
Industry
ViewMarkets
ViewProcesses
ViewDiseases
ViewPublic health challenges
ViewElectronics
ViewEngineering & Construction
ViewScience & New energies
ViewLarge projects
ViewQuick Access
Diabetes
A genuinely global epidemic1
number of diabetics in the world¹
number of people around the world unaware of being diabetic²
Three forms of diabetes
Three forms of diabetes affect three different types of people:
- Type 1 (or juvenile) diabetes is an autoimmune disease seen mainly in children and young adults
- Type 2 or non-insulin-dependent diabetes accounts for 90% of all diabetes cases3
- Gestational diabetes is characterized by chronic hyperglycemia in pregnancy, which in most cases disappears once the baby is born
The need for diagnosis
Hyperglycemia or the excessively high blood glucose levels that result from diabetes can result in complications that compromise affect the quality of life and threaten the life expectancy of patients.
Currently 212 million2 people around the world are unaware of the fact that they have diabetes.
Left undiagnosed or incorrectly treated, diabetes can have serious long-term consequences for the body, including:
- Cardiovascular disease (coronary artery disease, heart attack, cerebrovascular accidents), which is the principal cause of death from diabetes
- Kidney failure, blindness, lower limb nerve damage, chronic lesions which could lead to amputation
Long-term treatment4-5-6
The recommended treatments to achieve a better glycemic balance are specific to each type of diabetes.
The only treatment for type 1 diabetes is the administration of insulin, either in the form of injections with a syringe or pen, or using an insulin pump; a portable or implantable device that administers insulin continually to avoid the need for multiple injections.
Type 2 and gestational diabetes are treated initially through healthy lifestyle and dietary measures alone. Often associated with excess weight or obesity, diabete develops insidiously and may remain undiagnosed for long periods. For type 2 diabetes, oral anti-diabetic drugs may be prescribed in conjunction with lifestyle changes.
Insulin is administered only to those patients for whom these measures prove insufficient to achieve the required goals and glycemic balance.
For pregnant women, the preferred treatment is insulin, because oral anti-diabetic drugs are inadvisable in most cases.
In addition to taking these specific medications, diabetic patients must adopt lifestyle improvements, including a balanced diet, regular physical activity and zero tobacco.
Our commitment to diabetic patient quality of life
Air Liquide Healthcare contributes to the process of continual improvement in diabetes management, and is involved in the significant steps used in caring for diabetic patients which include the use of insulin pumps, to improve patient quality of life. Central to Air Liquide Healthcare mission is the dedication to monitoring and treatment optimization.
Assisting patients with diabetes
When insulin pump treatment is prescribed by a physician, the home healthcare provider contacts diabetic patients and supports them in their daily lives as they become insulin pump users. A wide range of services is available to these patients:
- Provision of the insulin pump
- Training and support in programming and using the pump
- Personal advice
- Home visits
- Support service
To ensure treatment optimization and compliance, the home healthcare provider keeps the prescribing physician regularly updated on its monitoring of insulin pump patients.
References:
- IDF. Diabetes Atlas 8th edition 2017, page 41. Available at: http://diabetesatlas.org/resources/2017-atlas.html
- IDF. Diabetes Atlas 8th edition 2017, page 47. Available at: http://diabetesatlas.org/resources/2017-atlas.html,
- WHO, Diabetes, Fact sheet, January 2015. Available at: https:www.who.int/mediacentre/factsheets/fs312/en/
- Mac Gibbon a, Richardson C, Hernandez C et al. Pharmacotherapy in Type 1 Diabetes. Canadian Journal of Diabetes 2013; 37:S56-S60.
- Harper W, Clement M, Goldenberg R et al. Pharmacologic management of Type 2 Diabetes. Canadian Journal of Diabetes 2013; 37:S61-S68
- Fédération Française des Diabétiques. Qu’est-ce que le diabète ? Available at: www.afd.asso.fr/diabete.
